ADT	androgen deprivation therapy
AUC	area under the curve
CT	computed tomography
CLIA	chemiluminescent assay
CRPC	castrate resistant prostate cancer
DES	diethylstilbestrol
dL	deciliter
Gn	gonadotropin
GC	gas chromatography
LC	liquid chromatography
LH	luteinising hormone
SHBG	sex hormone binding globulin
FDA	Food and Drug Administration
Ga	gallium
L	litre
M	metastases
mL	milliliter
MRI	magnetic resonance imaging
MS	mass spectrometry
ng	nanogram
nmol	nanomole
PCa	prostate cancer
PCWG	prostate cancer working group
PET	positron emission tomography
PSMA	prostate specific membrane antigen
RIA	radioimmunoassay
RECIST	response evaluation criteria solid tumour
RH	releasing hormone
UI	unit international per litre
VACURG	Veterans’ Administration Cooperative Research Group